We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current TLRY market cap is 1.03B. The company's latest EPS is USD -0.2613 and P/E is -4.17.
Quarter End | Nov 2023 | Feb 2024 | May 2024 | Aug 2024 | Nov 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 193.47M | 194.32M | 228.88M | 200.04M | 210.95M |
Operating Income | -41.78M | -82.08M | -20.72M | -36.57M | -42.22M |
Net Income | -49.01M | -92.7M | -31.75M | -39.17M | -85.34M |
Year End May 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 210.48M | 513.09M | 673.02M | 627.63M | 804.73M |
Operating Income | -186.97M | -132.63M | -611.08M | -1.37B | -178.94M |
Net Income | -271.07M | -367.42M | -476.8M | -1.45B | -244.98M |
Quarter End | Nov 2023 | Feb 2024 | May 2024 | Aug 2024 | Nov 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 4.33B | 4.21B | 4.22B | 4.26B | 4.19B |
Total Liabilities | 937.2M | 869.82M | 778.49M | 778.45M | 738.15M |
Total Equity | 3.39B | 3.34B | 3.44B | 3.48B | 3.45B |
Year End May 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 945.95M | 6.03B | 5.45B | 4.31B | 4.22B |
Total Liabilities | 572.05M | 1.56B | 1.01B | 977.32M | 778.49M |
Total Equity | 373.9M | 4.47B | 4.44B | 3.33B | 3.44B |
Quarter End | Nov 2023 | Feb 2024 | May 2024 | Aug 2024 | Nov 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -46.25M | -61.61M | -30.91M | -35.31M | -76.03M |
Investing | 55.21M | 83.29M | 128.35M | -49.4M | -60.12M |
Financing | -71.35M | -82.26M | -75.19M | 60.59M | 98.79M |
Year End May 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -129.35M | -44.72M | -177.26M | 7.91M | -30.91M |
Investing | -41.68M | 46.11M | -21.53M | -285.11M | 128.35M |
Financing | 264.85M | 124.31M | 128.2M | 70.16M | -75.19M |
Market Cap | 1.03B |
Price to Earnings Ratio | -4.17 |
Price to Sales Ratio | 1.27 |
Price to Cash Ratio | 4.48 |
Price to Book Ratio | 0.3 |
Dividend Yield | - |
Shares Outstanding | 937.66M |
Average Volume (1 week) | 38.71M |
Average Volume (1 Month) | 42.56M |
52 Week Change | -42.42% |
52 Week High | 2.97 |
52 Week Low | 1.08 |
Spread (Intraday) | 0.01 (0.91%) |
Company Name | Tilray Brands Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.tilray.com |
Industry | medicinal chems,botanicl pds (2833) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions